icecure-medical.com (ICCM) - Cash per Single Share

The liquid assets per share metric demonstrates the financial stability of IceCure Medical Ltd (ICCM), with the indicator currently standing at 2.38. High demand for minimally invasive freezing of neoplasms allows the company to maintain pricing power for its systems. Leading biomedical experts who value scientific progress drive business growth, while development proceeds through the automation of nitrogen delivery and the implementation of robotic software.
Comprehensive metric breakdowns and analytics for IceCure Medical Ltd. (ICCM)

IceCure Medical Ltd (ICCM) monetizes the supply of cryoablation systems and consumables for non-surgical oncology treatment. This cash flow directly impacts the liquidity measured by the indicator's calculation model. The metric determines the share of cash reserves per common share, revealing the real value of defensive capital. An increase in this value signals financial stability and expansion potential. By analyzing the company's cash per share, an investor assesses the balance between risk and reliability.